Neovaccinationer administreret under Raptiva behandlingen kan give lavere antistofniveauer end hos patienter der ikke er i behandling, men den kliniske signifikans er ukendt.
Neo-vaccinations given during treatment with Raptiva may induce antibody levels lower than non-treated subjects, but the clinical significance of this is unknown.